MedTrace Logo

Clinical Trial to Evaluate the Effects of a Nutraceutical in Patients Affected by Knee Osteoarthritis

NCT03612986 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 72

Last updated 2019-10-02

No results posted yet for this study

Summary

Double blind, placebo controlled trial to evaluate the effects of a nutraceutical containing high-molecular-weight hyaluronic acid (HA) and acetyl-11-keto-beta-boswellicacid (AKBA) in patients affected by knee osteoarthritis.

Conditions

Interventions

DIETARY_SUPPLEMENT

SYALOX® 300 Plus

Reduction of pain and improvement of the knee mobility in patients affected by knee osteoarthritis

DIETARY_SUPPLEMENT

Placebo

Placebo comparator. No chemical effect expected

Sponsors & Collaborators

  • River Pharma S.r.l.

    lead OTHER

Principal Investigators

  • Bogdan Andor, MD · MEDICALI'S

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
45 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-08-22
Primary Completion
2019-04-10
Completion
2019-07-26

Countries

  • Romania

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03612986 on ClinicalTrials.gov